The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 12,033 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,124 | 207,200 | SH | Put | SOLE | 207,200 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 10,588 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ACORDA THERAPEUTICS INC | COM | 00484M106 | 6,300 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ADURO BIOTECH INC | COM | 00739L101 | 8,600 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 9,977 | 220,000 | SH | Call | SOLE | 220,000 | 0 | 0 | |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 7,300 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 516 | 46,622 | SH | SOLE | 46,622 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 3,755 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | COM | 053588109 | 885 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 13,305 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 12,600 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 3,999 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 11,192 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 8,157 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
CLOVIS ONCOLOGY INC | COM | 189464100 | 12,734 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 3,773 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
CONFORMIS INC | COM | 20717E101 | 2,088 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
CURRENCYSHARES SWISS FRANC T | SWISS FRANC SH | 23129V109 | 1,835 | 19,300 | SH | SOLE | 19,300 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 2,150 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 17,610 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 2,217 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 9,240 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 9,412 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
ENTELLUS MED INC | COM | 29363K105 | 5,175 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 10,290 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 619 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
GENMARK DIAGNOSTICS INC | COM | 372309104 | 8,333 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 9,705 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 4,678 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 2,438 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
IRIDEX CORP | COM | 462684101 | 2,968 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 34,370 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
K2M GROUP HLDGS INC | COM | 48273J107 | 5,845 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
LION BIOTECHNOLOGIES INC | COM | 53619R102 | 8,940 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 9,531 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 895 | 172,184 | SH | SOLE | 172,184 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 7,948 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 12,990 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 7,011 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 8,962 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 5,366 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 7,838 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 5,579 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 1,968 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 8,370 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 6,387 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 3,641 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 7,107 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 12,572 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 5,227 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 10,668 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 23,574 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 62,406 | 900,000 | SH | Put | SOLE | 900,000 | 0 | 0 | |
SPECTRANETICS CORP | COM | 84760C107 | 4,514 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 9,464 | 325,000 | SH | Call | SOLE | 325,000 | 0 | 0 | |
STEMLINE THERAPEUTICS INC | COM | 85858C107 | 1,924 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 7,694 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 9,842 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 5,757 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 600 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 12,211 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 3,960 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
ZOSANO PHARMA CORP | COM | 98979H103 | 1,786 | 940,000 | SH | SOLE | 940,000 | 0 | 0 |